These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37169576)

  • 1. Hyperthyroidism in a 15-year-old adolescent treated with Dupilumab for severe allergic asthma and atopic dermatitis.
    Tosca MA; Olcese R; Girosi D; Casalini E; Scaglione M; Ciprandi G
    Allergol Immunopathol (Madr); 2023; 51(3):181-185. PubMed ID: 37169576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Principles of modern diagnosis and treatment of atopic dermatitis and bronchial asthma: Clinical case].
    Shogenova MS; Hutueva SH; Shogenova LS
    Ter Arkh; 2022 Mar; 94(3):427-433. PubMed ID: 36286909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of dupilumab-associated ocular surface diseases in atopic dermatitis patients.
    Guex-Crosier Y; Di-Lucca J; Häusermann P; Laffitte E; Saulite I; Schmid-Grendelmeier P; Schürch K; Thormann K; Simon D
    Swiss Med Wkly; 2021 Aug; 151():w30020. PubMed ID: 34495603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
    Blauvelt A; de Bruin-Weller M; Gooderham M; Cather JC; Weisman J; Pariser D; Simpson EL; Papp KA; Hong HC; Rubel D; Foley P; Prens E; Griffiths CEM; Etoh T; Pinto PH; Pujol RM; Szepietowski JC; Ettler K; Kemény L; Zhu X; Akinlade B; Hultsch T; Mastey V; Gadkari A; Eckert L; Amin N; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Shumel B
    Lancet; 2017 Jun; 389(10086):2287-2303. PubMed ID: 28478972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dupilumab: A review of its use in the treatment of atopic dermatitis.
    Gooderham MJ; Hong HC; Eshtiaghi P; Papp KA
    J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S28-S36. PubMed ID: 29471919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial.
    Thaçi D; Simpson EL; Beck LA; Bieber T; Blauvelt A; Papp K; Soong W; Worm M; Szepietowski JC; Sofen H; Kawashima M; Wu R; Weinstein SP; Graham NM; Pirozzi G; Teper A; Sutherland ER; Mastey V; Stahl N; Yancopoulos GD; Ardeleanu M
    Lancet; 2016 Jan; 387(10013):40-52. PubMed ID: 26454361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative efficacy of systemic treatments for atopic dermatitis.
    Seger EW; Wechter T; Strowd L; Feldman SR
    J Am Acad Dermatol; 2019 Feb; 80(2):411-416.e4. PubMed ID: 30296535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beginning of biological treatment era in the atopic dermatitis management.
    D'erme AM
    Dermatol Ther; 2016 May; 29(3):208-9. PubMed ID: 26331894
    [No Abstract]   [Full Text] [Related]  

  • 9. Omalizumab for treatment of refractory severe atopic dermatitis. A pediatric perspective.
    Iannelli M; Caminiti L; Vaccaro M; Marafioti I; Spinuzza A; Panasiti I; Barbalace A; Crisafulli G; Pajno GB
    Dermatol Ther; 2020 Jul; 33(4):e13519. PubMed ID: 32378300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE).
    Blauvelt A; Guttman-Yassky E; Paller AS; Simpson EL; Cork MJ; Weisman J; Browning J; Soong W; Sun X; Chen Z; Kosloski MP; Kamal MA; Delevry D; Chuang CC; O'Malley JT; Bansal A
    Am J Clin Dermatol; 2022 May; 23(3):365-383. PubMed ID: 35567671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Application of Dupilumab to Pediatric Patients Aged 6-11yrs with Moderate-to-Severe Atopic Dermatitis Whose Disease is Not Adequately Controlled: The Clinical Data so Far.
    Balboul S; Kahn J; Tracy A; Peacock A; Cline A
    Drug Des Devel Ther; 2023; 17():1323-1327. PubMed ID: 37152103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eye Complications During Dupilumab Treatment for Severe Atopic Dermatitis.
    Ivert LU; Wahlgren CF; Ivert L; Lundqvist M; Bradley M
    Acta Derm Venereol; 2019 Apr; 99(4):375-378. PubMed ID: 30653240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dupilumab: First Global Approval.
    Shirley M
    Drugs; 2017 Jul; 77(10):1115-1121. PubMed ID: 28547386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dupilumab for the Treatment of Atopic Dermatitis.
    Ferreira S; Torres T
    Actas Dermosifiliogr (Engl Ed); 2018 Apr; 109(3):230-240. PubMed ID: 29422431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers.
    Bakker DS; Ariens LFM; Giovannone B; Hijnen D; Delemarre EM; Knol E; Nierkens S; de Bruin-Weller MS; Thijs JL; Drylewicz J
    Allergy; 2020 Dec; 75(12):3287-3289. PubMed ID: 33305359
    [No Abstract]   [Full Text] [Related]  

  • 16. Painless thyroiditis in a dupilumab-treated patient.
    Narantsatsral D; Junko T; Hideyuki I; Daisuke I; Hiroyuki T; Yuka N; Syo H; Hiroyuki M; Kazuo O; Tetsuya O; Akiyoshi T
    Endocrinol Diabetes Metab Case Rep; 2020 Jun; 2020():. PubMed ID: 32554823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuating the atopic march: Meta-analysis of the dupilumab atopic dermatitis database for incident allergic events.
    Geba GP; Li D; Xu M; Mohammadi K; Attre R; Ardeleanu M; Musser B
    J Allergy Clin Immunol; 2023 Mar; 151(3):756-766. PubMed ID: 36084766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis.
    Paller AS; Siegfried EC; Cork MJ; Wollenberg A; Arkwright PD; Gonzalez ME; Lockshin B; Chen Z; Bansal A; Levit NA; Prescilla R
    Paediatr Drugs; 2023 Jan; 25(1):67-77. PubMed ID: 36529811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dupilumab for the treatment of atopic dermatitis: A clinical trial review.
    McGregor S; Farhangian ME; Feldman SR
    Expert Opin Biol Ther; 2015; 15(11):1657-60. PubMed ID: 26428945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal Antibodies (Biologics) for Allergic Rhinitis, Asthma, and Atopic Dermatitis During Pregnancy and Lactation.
    L Ramos C; Namazy J
    Immunol Allergy Clin North Am; 2023 Feb; 43(1):187-197. PubMed ID: 36411004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.